Barclays PLC Tango Therapeutics, Inc. Put Options Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TNGX
# of Institutions
124Shares Held
117MCall Options Held
245KPut Options Held
19.5K-
Trv Gp Iv, LLC Boston, MA16.9MShares$153 Million97.21% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$97.3 Million11.21% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$96.3 Million4.69% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.16MShares$83 Million0.21% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$54.6 Million0.18% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $798M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...